Joseph R. Biden, Jr.
As a Senator from Delaware for 36 years, Vice President Biden was a leader in facing some of our nation’s most important domestic and international challenges. As Chairman or Ranking Member of the Senate Judiciary Committee for 17 years, he was widely recognized for his work on criminal justice issues, including the landmark 1994 Crime Act and the Violence Against Women Act. As Chairman or Ranking Member of the Senate Foreign Relations Committee for 12 years, Biden played a pivotal role in shaping U.S. foreign policy.
As the 47th Vice President of the United States, Joe Biden continued his leadership on important issues facing the nation and represented our country abroad. Biden led the White House Cancer Moonshot, which resulted in more than 80 new actions and collaborations from the public and private sectors to speed progress in cancer prevention, diagnosis, treatment, and care, and worked with Congress to authorize an additional $1.8Billion for investment in cancer research. Biden oversaw the implementation of the American Recovery and Reinvestment Act and chaired the Middle-Class Task Force.
In January, President Obama awarded Biden the Presidential Medal of Freedom, with Distinction – the highest civilian honor in the United States.
Jill Biden, Ed.D.
Dr. Jill Biden is a mother and grandmother, a lifelong educator, and a former Second Lady of the United States.
Dr. Biden’s passion for finding a cure began in 1993, when four of her friends were diagnosed with breast cancer. Hoping to use her decades-long education background to promote prevention, she started the Biden Breast Health Initiative in Delaware, which has educated more than 10,000 high school girls about the importance of early detection of breast cancer.
Later, after losing both parents to the disease, and helping to nurse her sister through a stem cell transplant, she was inspired to use her role as Second Lady to raise awareness and support research. In Washington, D.C., Dr. Biden and the Vice President served – and continue to serve – as the Honorary Co-Chairs for the Global Race for the Cure.
Following the death of their son Beau to brain cancer in 2015, Vice President and Dr. Biden helped push for a national commitment to ending cancer as we know it, known as the White House Cancer Moonshot. Today, they continue that mission through the Biden Cancer Initiative, hoping to inject a sense of urgency into cancer research and care, and to deliver better outcomes for patients.
David B. Agus, M.D.
Dr. David B. Agus is a professor of medicine and engineering at the University of Southern California. He is the founding director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine of USC. A medical oncologist, Dr. Agus leads a multidisciplinary team of clinicians and researchers dedicated to the development and use of technologies to guide doctors in making healthcare decisions tailored to individual needs.
Dr. Agus served in leadership roles at the World Economic Forum and is a CBS News contributor. Dr. Agus’ three books “The End of Illness”, “A Short Guide to a Long Life” and “The Lucky Years: How to Thrive in the Brave New World of Health” are all New York Times and international bestsellers.
As part of FOX Sports’ “A Team,” Erin Andrews currently reports for FOX NFL Sunday, for sideline coverage and features, a show that records a staggering 56.4 million unique viewers. Andrews recently wrapped her 6th season as Co-Host of ABC’s long-running reality series, Dancing with the Stars, alongside Tom Bergeron this fall. Having a unique perspective on the competition, Erin was also a contestant in 2010, where she was paired with Maksim Chmerkovkiy and earned third place.
Recent notable appearances include her coverage of Super Bowl LI & Super Bowl XLVIII, the 2015 & 2014 World Series and host of FOX’s Prime Time College Football Pregame Show. Prior to her move to FOX, Andrews spent eight years at ESPN where she hosted the first hour of ESPN’s College GameDay on ESPNU and was a features reporter for the full three-hour program, congruently serving as a sideline reporter for NCAA football and basketball games.
Erin began her career with Fox Sports-Florida South as a freelance reporter and Tampa Bay Lightning reporter for the Sunshine Network. She joined ESPN in May 2004 as a reporter for the network’s National Hockey League coverage and quickly become a fan favorite, transitioning into college football, basketball, baseball and Major League Baseball.
Photo by: Brian Bowen Smith
Elizabeth Blackburn, Ph.D.
Elizabeth Blackburn, Ph.D., President of the Salk Institute, won the Nobel Prize in Physiology or Medicine in 2009 for discovering the molecular nature of telomeres, the ends of chromosomes that serve as protective caps essential for preserving genetic information, and for co-discovering telomerase, an enzyme that maintains telomere ends. Both telomeres and telomerase are thought to play central roles in aging and diseases such as cancer, and her work helped launch entire new fields of research in these areas.
In addition to the Nobel Prize, Dr. Blackburn has received nearly every major science award including the Lasker, Gruber and Gairdner prizes. Helping to guide public science policy, she was a member of the Stem Cell Research Advisory Panel for the California State Legislature and a member of the President’s Council of Bioethics, an advisory committee to the President of the United States.
David G. Bradley
Mr. Bradley is chairman of Atlantic Media, whose holdings include The Atlantic, Quartz, National Journal Daily, National Journal Membership, The Hotline, and Government Executive Media Group. At the age of 26, he launched his first company, the Advisory Board Company, a for-profit think tank ultimately serving 4,000 corporations, financial institutions, and medical centers around the world. The Advisory Board company and its sister enterprise, the Corporate Executive Board, today are public companies listed on NASDAQ. During his early 20s, Mr. Bradley was a Fulbright Scholar in the Philippines. He graduated from Swarthmore College, holds an M.B.A. from Harvard Business School, a J.D. from Georgetown University, and, more recently, an Honorary Doctorate of Letters from Swarthmore. Board memberships include the Council on Foreign Relations, New America Foundation and KIPP DC. He is based in Washington, D.C.
Carol L. Brown, M.D.
Carol L. Brown, M.D., a board-certified Gynecologic Oncologist, is the Associate Cancer Center Director for Diversity and Outreach at Memorial Sloan Kettering Cancer Center. She holds academic appointments as Attending Surgeon and Member, Memorial Sloan Kettering Cancer Center, and Professor, Obstetrics and Gynecology at Weill Cornell Medical College.
Dr. Brown’s career is dedicated to providing high-quality and compassionate surgical care to women with gynecologic cancer, reduction and elimination of cancer health disparities experienced by medically underserved populations, and promoting public policy to increase awareness, improve care, and increase research funding for gynecologic and other cancers locally and nationally.
Jimmy “Taboo” Gomez
Jimmy Gomez, also known to his band mates and fans as “Taboo”, is not just a member of the global chart-topping sensation, The Black Eyed Peas, but also a cancer survivor.
Born in East Los Angeles, Taboo followed his dream of being an entertainer and rose from humble beginnings to unimaginable success. With singles like “Boom Boom Pow” and “I gotta feelin”, BEP had a record 27 consecutive weeks atop Billboard’s hot 100 chart. Having sold a staggering 65 million albums worldwide, Taboo is now a driving force behind BEP’s return to the spotlight in 2017.
Julie Papanek Grant, M.B.A., M.Phil.
Julie Papanek Grant is a Partner at Canaan Partners, an early-stage technology and healthcare venture capital firm with over $3.5 billion under management. During her four years at Canaan, Julie has led and co-sponsored numerous investments across biopharmaceuticals, life science tools, and digital health start-ups including Cellular Research (acquired by Becton Dickinson) and Protagonist Therapeutics (IPO in 2016).
Prior to Canaan, Julie’s held positions focused on new oncology therapies across Roche and Genentech’s Development and Commercial organizations. Julie holds an M.B.A. from Stanford’s Graduate School of Business, an M.Phil. from Cambridge University in BioScience Enterprise and a B.S. from Yale University in Molecular Biophysics and Biochemistry.
Kurt Grote, M.D.
Kurt Grote is a Senior Partner in McKinsey & Company’s North American Healthcare Systems and Services Practice, and leads the Firm’s work with Cancer Centers. Dr. Grote supports CEOs and top teams of the largest healthcare providers across the Americas to improve performance with a focus on improving patient outcomes and optimizing labor and supply deployment. Dr. Grote’s extensive research work has focused on physician-system alignment, clinical quality enhancement, and health system performance in the face of healthcare reform.
Prior to joining McKinsey, Dr. Grote earned M.D. and B.A. degrees from Stanford University. He also served as captain of the U.S. National Swim Team and was an Olympic Gold Medalist in the 1996 Games, and in the 1998 World Championships. During this period, he worked with major pharmaceutical companies to promote swimming as part of a treatment regimen for asthmatic children.
Elizabeth Jaffee, M.D.
Dr. Elizabeth Jaffee is the Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, the Dana and Albert “Cubby” Broccoli Professor of Oncology and the Co-Director of the Skip Viragh Center for Pancreas Cancer. She has served on many committees at the National Cancer Institute and is currently Chair of the National Cancer Advisory Board.
Dr. Jaffee served as co-chair of the Blue Ribbon Panel that provided scientific advice for Vice President Joe Biden’s Moonshot Initiative. Dr. Jaffee is the 2015 American Association for Cancer Research (AACR) Burchenal Award Recipient and is Present-Elect of AACR for the 2017-2018 term. Her interests are in vaccine and immunotherapy development for pancreatic and breast cancers.
Howard Krein, M.D., Ph.D.
Dr. Krein currently serves as Senior Director of Health Policy & Innovation of the Sidney Kimmel Cancer Center at Thomas Jefferson University. He is an Associate Professor of Otolaryngology: Head & Neck Surgery/Microvascular Surgery at Thomas Jefferson University Hospital where he specializes in cancer reconstruction. Dr. Krein is Chief Medical Officer at StartUp Health, which is organizing and supporting an army of Health Transformers. Dr. Krein received his M.D. from Thomas Jefferson Medical College in Philadelphia and a Ph.D. in Cell and Developmental Biology from UMDNJ/Robert Wood Johnson Medical School.
Eric S. Lander, Ph.D.
Dr. Eric Lander is president and founding director of the Broad Institute of MIT and Harvard. A geneticist, molecular biologist, and mathematician, Dr. Lander has played a pioneering role in all aspects of the reading, understanding, and biomedical application of the human genome. He was one of the principal leaders of the international Human Genome Project (HGP) from 1990 to 2003, with his center being the largest contributor to the mapping and sequencing of the human blueprint.
With his colleagues, Dr. Lander has developed and applied methods for discovering the molecular basis of rare genetic diseases, common diseases, and cancer. He has done pioneering work on genetic variation, population history, evolutionary forces, regulatory elements, long non-coding RNAs, three-dimensional folding of the human genome, and methods to systematically identify the genes essential for biological processes. Dr. Lander is professor of biology at MIT and professor of systems biology at Harvard Medical School. In 2008, Dr. Lander was appointed by President Obama as co-chair of the President’s Council of Advisors on Science and Technology. Dr. Lander earned his B.A. in mathematics from Princeton University (1978) and his Ph.D. in mathematics from Oxford University (1981) as a Rhodes Scholar.
Todd Park is Co-Founder and Executive Chairman of Devoted Health. Prior to co-founding Devoted, Todd served as White House technology advisor based in Silicon Valley until January 2017. In this role, he focused on bringing top technology talent and best practices into government to improve service delivery, national defense, public engagement, and more. Prior to this role, Todd served from March 2012 to August 2014 as U.S Chief Technology Officer (CTO) in the White House Office of Science and Technology Policy, and, in that position, served as an Assistant to the President. Todd joined the Obama Administration in August 2009 as CTO of the U.S. Department of Health and Human Services (HHS), where he functioned as an “entrepreneur-in-residence,” helping HHS harness the power of data, technology, and innovation to improve the health of the nation. For his work at HHS, Todd was named one of Fast Company’s “100 Most Creative People in Business” in 2010.
Prior to his work in government, Todd co-founded Athenahealth in 1997 and co-led its development over a decade into a leading provider of cloud-based software and services for physicians and health care practitioners. He also co-founded Castlight Health, an innovative online health benefits platform company, in 2008, and has served as a senior advisor to Ashoka, a global incubator of social entrepreneurs, where he helped start a venture to bring affordable telehealth, drugs, diagnostics, and clean water to rural India. Todd graduated magna cum laude and Phi Beta Kappa from Harvard College with an A.B. in economics. He currently serves on the boards of New America and the Biden Cancer Initiative. Todd was elected a Fellow of the National Academy of Public Administration in 2017, and is a member of the 2017 Class of Henry Crown Fellows within the Aspen Global Leadership Network at the Aspen Institute.
Susan M. Schneider, PhD, RN, AOCN, FAAN
Dr. Susan Schneider is an Associate Professor and Lead Faculty for the Oncology Nursing Specialty at Duke University. Dr. Schneider is Immediate Past President of the Oncology Nursing Society, a professional nursing organization of nearly 40,000 members whose mission is “Advancing Excellence in Oncology Nursing and Quality Cancer Care.”
Dr. Schneider has extensive experience as a clinical nurse, advanced practice nurse and researcher caring for individuals with cancer. As a researcher, Dr. Schneider has focused on developing interventions to manage symptom distress in order to improve cancer patients’ quality of life and increase survival. As an educator, Dr. Schneider has devoted her teaching career to the development of oncology nurse leaders. She is a Fellow in the American Academy of Nursing. As an influential nursing leader, Dr. Schneider uses her clinical expertise to advocate for quality care for the cancer population.
President, Biden Cancer Initiative
Gregory C. Simon, J.D.
President, Biden Cancer Initiative
Greg Simon served as the Executive Director of the White House Cancer Moonshot Task Force, a position created by President Barack Obama and for which he was chosen by Vice President Joe Biden in March 2016. Over nine months, Greg and his team helped launch over seventy innovative collaborations. Greg returned to the White House after serving as Vice President Al Gore’s Chief Domestic Policy Advisor between 1993 and 1997.
Greg was the CEO of Poliwogg, a financial services company creating unique capital market opportunities in healthcare and life sciences. Previously, he was Senior Vice President for Worldwide Policy and Patient Engagement at Pfizer, co-founded with Michael Milken, FasterCures/ The Center for Accelerating Medical solutions, and with Leon and Debra Black co-founded the Melanoma Research Alliance. Greg is a cancer survivor, having been recently successfully treated for chronic lymphocytic leukemia.
Kim Thiboldeaux joined The Wellness Community in 2000 as President and CEO. In 2009, the headquarters offices of The Wellness Community and Gilda’s Club joined forces to become the Cancer Support Community, one of the largest providers of social and emotional support worldwide, where Kim has maintained her role as CEO. Formerly the Director of Patient Relations for Oncology & Transplant at Hoffmann-LaRoche, Inc., Kim brings to this position a wealth of experience in healthcare, patient education and national patient advocacy.
Prior to joining Roche, Kim served as the Director of Corporate Relations at Whitman-Walker Clinic, a Washington, D.C.-based health clinic that provides comprehensive services to people with HIV and AIDS. Kim is the co-author of “Reclaiming Your Life After Diagnosis” (2012), and “The Total Cancer Wellness Guide” (2007). She is the host of Frankly Speaking About Cancer with the Cancer Support Community, an award-winning Internet talk radio show that airs weekly on VoiceAmerica.com and is aimed at informing and inspiring listeners to live well with cancer. Kim is also a regular contributor to The Huffington Post.
Across a 20-year career in business, Jeff Zients built and led a number of high-performing organizations. He served as the CEO and Chairman of The Advisory Board Company which he joined in 1992. Across his tenure, Mr. Zients helped create more than $2 billion in equity value. Most recently, Mr. Zients served in the Obama Administration White House from 2009 to 2017, including as Director of the National Economic Council (NEC). Prior, Mr. Zients spearheaded the turnaround of the failed healthcare.gov website launch, and served as the acting Director of the Office of Management and Budget (OMB). Mr. Zients was first recruited into the Administration and appointed by President Obama to the newly created position of United States Chief Performance Officer, and was confirmed by the Senate as Deputy Director for Management at OMB. Mr. Zients is a co-founder of The Urban Alliance Foundation, a non-profit organization that partners with corporations to provide economically disadvantaged youth with year-round paid internships, adult mentors, and job training. He graduated summa cum laude from Duke University.